Decision Date2019-01-04
Product CodeHQD
Advisory CommitteeOP
DecisionSubstantially Equivalent
Device Summary
BostonSight Scleral is a medical device manufactured by Bostonsight. It received FDA 510(k) clearance on 2019-01-04 under approval number K183175. The device is classified under product code HQD. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the BostonSight Scleral?
BostonSight Scleral is a medical device that received FDA 510(k) clearance on 2019-01-04. It is manufactured by Bostonsight. The 510(k) number is K183175.
When was BostonSight Scleral approved by the FDA?
BostonSight Scleral received FDA 510(k) clearance on 2019-01-04, under approval number K183175.
What company makes BostonSight Scleral?
BostonSight Scleral is manufactured by Bostonsight.
What is the FDA product code for BostonSight Scleral?
The FDA product code for BostonSight Scleral is HQD.
Other Devices by Bostonsight
Related Devices (Code: HQD)
K162005Acuity 100 (hexafocon A) Rigid Gas Permeable Contact LensAcuity Polymers, Inc.
K153714SynergEyes A&M (paflufocon D hem-iberfilcon A) Hybrid Daily Wear Contact Lens, SynergEyes KC (paflufocon D hem-iberfilcon A) Hybrid Daily Wear Contact Lens, SynergEyes PS (paflufocon D hem-iberfilcon A) Hybrid Daily Wear Contact Lens, SynergEyes SiH (petrafocon A hem-larafilcon A) Hybrid Daily Wear Contact Lens, SynergEyes UltraHealth for Keratoconus (petrafocon A hem-larafilcon A) Hybrid Daily Wear CoSynergeyes, Inc.
K161100Optimum GP with HPT (roflufocon A, B, C, D, and E) Daily Wear Contact LensesContamac, Ltd.
K160938SynergEyes SiH with Hydra-PEG(petrafocon A hem-larafilcon A) Hybrid Daily Wear LensSynergeyes, Inc.
K161461BostonSight PD Prosthetic DeviceBostonsight
K152724EYEPRINTPRO (ROFLUFOCON D) SCLERAL GP LENSESAdvanced Vision Technologies
Official Source
View on FDA Database →
Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.